logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

C CARBONNEUTRAL (01372) issued 206 million shares due to the conversion of convertible bonds.

date
12:15 12/05/2026
avatar
GMT Eight
China Carbon Neutrality (01372) announced that on May 11, 2026, the company issued 206 million shares due to the conversion of convertible bonds.
C CARBONNEUTRAL (01372) has announced that on May 11, 2026, the company issued 206 million shares due to the conversion of convertible bonds.
Related Articles
HK Stock
KUAISHOU-W(01024) clarifies rumors about the split of Coolin AI: Currently evaluating restructuring plan, final agreement has not been signed yet.
HK Stock
GALAXY ENT (00027) net profit for the first quarter was 12.4 billion Hong Kong dollars, up 11% year-on-year.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276) signs strategic cooperation and licensing agreement with Bristol-Myers Squibb.
KUAISHOU-W(01024) clarifies rumors about the split of Coolin AI: Currently evaluating restructuring plan, final agreement has not been signed yet.
HK Stock
GALAXY ENT (00027) net profit for the first quarter was 12.4 billion Hong Kong dollars, up 11% year-on-year.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276) signs strategic cooperation and licensing agreement with Bristol-Myers Squibb.
HK Stock
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
icon
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
icon
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
The Chip Stock Frenzy Is Still Accelerating
icon
11/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.